(Q41647745)

6 October 2017

1 reference

title

Crosstalk of the heart and periphery: skeletal and cardiac muscle as therapeutic targets in heart failure (English)

1 reference

6 October 2017

A Gordon

1

1 reference

6 October 2017

L M Voipio-Pulkki

series ordinal

2

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

29

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

327-331

1 reference

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

The development of positive inotropic agents for chronic heart failure: how have we gone astray?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Hemodynamic adaptations to exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Maximal perfusion of skeletal muscle in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Factors contributing to the exercise limitation of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Improved quality of life in chronic heart failure patients following local endurance training with leg muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

21 January 2018

Apoptosis in the heart.

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899708999356

10.3109/07853899708999356

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference